FITY (Fifty 1 Labs) Long-Term Debt: $0.00 Mil (As of Jun. 2024)


What is Fifty 1 Labs Long-Term Debt?

Fifty 1 Labs FITY Long-Term Debt is $0.00 Mil as of Jun. 2024.

Fifty 1 Labs's Long-Term Debt for the quarter that ended in Jun. 2024 was $0.00 Mil.

Fifty 1 Labs  (OTCPK:FITY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Fifty 1 Labs Long-Term Debt Related Terms

Fifty 1 Labs Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Fifty 1 Labs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fifty 1 Labs Long-Term Debt Chart

Fifty 1 Labs Annual Data
Trend Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fifty 1 Labs Semi-Annual Data
Dec03 Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
Fifty 1 Labs (FITY) has a Long-Term Debt of $0.00 Mil as of Jun. 2024.
Is Fifty 1 Labs' Long-Term Debt too high?
Fifty 1 Labs' current Long-Term Debt is $0.00 Mil.
How does Fifty 1 Labs' Long-Term Debt compare to GRPS and KOAN?
Fifty 1 Labs' Long-Term Debt of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Fifty 1 Labs's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current Long-Term Debt is $0.00 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fifty 1 Labs Business Description

Address 1505 West 2nd Avenue, Suite 506, Melbourne, FL, USA, V6J 1H2
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.